Science Friday > Archives > 2004 > February
> February 20,
2004:
Hour One: White House Science Policy / Cancer News
Last week, the FDA approved the drug Erbitux -- a so-called "targeted cancer therapy" that could help those in the late stages of colon cancer. The medication is the latest addition to a relatively new class of cancer-fighting drugs called monoclonal antibodies. In this hour, we'll take a look at these, and other new cancer drugs. How are they changing the way we fight cancer?
We'll also take a look at the link between chronic antibiotic use and breast cancer. New research published this week suggests that there may be a correlation between antibiotic use and breast cancer risk, though scientists remain unsure whether or not there's a causative link between the two.
Plus, in a report published this week by the Union of Concerned Scientists, more than 60 big-name scientists have charged the Bush administration with manipulating science to suit its political agenda. We'll talk about it. Call in with your questions and comments at 1-800-989-8255 (2-3 Eastern), and share your opinions online in our Listeners' Lounge (registration required).
Guests:
John Marburger
Science Advisor to President George W. Bush
Director, Office of Science and Technology
Policy
Washington, DC
Neal Lane
Former Director, National Science Foundation
Science Advisor to President William J. Clinton
Former Director of the Office of Science
and Technology Policy
University Professor, Department of
Physics and Astronomy
Senior Fellow of the James
A. Baker III Institute for Public Policy
Rice University
Houston, Texas
Dr. Larry Norton
Deputy Physican in Chief for Breast
Cancer Programs
Memorial Sloan Kettering Cancer Center
New York, New York
Dr. Brian Druker
JELD-WEN Chair of Leukemia Research at the OHSU Cancer Institute
Howard Hughes Medical Investigator
Associate Professor, Medicine, Biochemistry and Molecular Biology, and
Cell and Developmental Biology
Co-Director,
Center
for Hematologic Malignancies
Oregon Health Science University, School
of Medicine
Portland, Oregon
This segment produced by Annette Heist
Archived Audio:
science policy
listen
in RealAudio format
listen
in Windows Media format
cancer
listen
in RealAudio format
listen
in Windows Media format
Related Links:
Union
of Concerned Scientists
OSTP
Office of Science and Technology Policy OSTP
AAAS
Science and Policy Programs
Bush
accused of distorting science
President's
Science Policy Questioned
Politics
& Science - Investigating the State of Science Under the Bush Administration
Cancer.gov
American
Cancer Society Homepage
OncoLink
ImClone
Systems IMC-C225
FDA
Approves Erbitux for Colorectal Cancer
Books/Articles Discussed:
"Scientific Integrity in Policymaking," Union of Concerned Scientists, 2004.
Copyright 2004 ScienceFriday Inc. All Rights Reserved.